 |
 |
 |
|
Incidence of Hepatocellular Carcinoma Among Patients With Hepatitis C Virus Infection Following Treatment With a Grazoprevir-Containing Regimen
|
|
|
Download the PDF here
Reported by Jules Levin
AASLD 2018 Nov 9-12 Boston
Brian Pearlman1; Eric Lawitz2; Tarik Asselah3; Joy Ginanni4; John Palcza4; Michael N. Robertson4;
Deanna Hill4; Barbara A. Haber4
1Atlanta Medical Center, Atlanta, GA, USA; 2Texas Liver Institute, University of Texas Health, San Antonio, TX, USA; 3Department of Hepatology, Hôpital Beaujon, Clichy, France; 4Merck & Co., Inc., Kenilworth, NJ, USA







|
|
|
 |
 |
|
|